Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.43NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HU.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JB.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.55NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HH.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FM.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EU.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EJ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KD.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XCSNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.15.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.40NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CR.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KB.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CJ.1.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XANNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AZ.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.97NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.32NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.59NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.67NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.28 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.272NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.371NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
AA.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.353NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.407NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AA.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.47NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.182NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.218NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.12.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.22 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.254NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.418NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.40NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.122NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used